Research / Funded grants
2011 Young Investigator
Ketamine for Rapid Reduction of Suicidal Ideation and Suicide Risk in Hospitalized Patients
James Murrough, M.D.
Mount Sinai School of Medicine
Mentor: Dennis S. Charney, M.D., Mount Sinai School of Medicine
$85,000 Focus area
Clinical Treatment Awarded
2011
Inside the Research
Research Categories: Major depression, ketamine
Abstract: Strong suicidal ideation is a medical emergency, and hospitals urgently need to identify fast-acting interventions that will help reduce imminent suicide risk. Ketamine may be one example of such a rapid intervention. Dr. Murrough will test the use of low doses of ketamine administered by IV for patients admitted to a psychiatric hospital for clinically significant suicidal ideation and elevated risk for suicide and examine its feasibility and tolerability. He will measure patients’ psychiatric and suicide symptoms at the time of admission and then again at 4 and 24 hours after treatment with ketamine. Dr. Murrough’s hypothesis is that ketamine will prove effective at rapidly reducing suicidal ideation. Further follow-ups to assess for safety and efficacy will be administered daily during hospitalization and weekly during the month following hospitalization, ending with one final assessment 6 months after the ketamine treatment.
Impact: To examine the short-term and long-term effects of ketamine as an acute treatment for clinically significant suicidal ideation and increased suicide.
Research Connection
This study is underway
Findings will be published here as the research progresses. to hear when they’re available.
More funded research
See all grants →2026 Early Career Researcher Grant
Analyzing the Impact of Companion Dogs as a Protective Factor for Prevention of Suicidality in Veterans
Leanne Nieforth, Ph.D. · $140,000
2026 Early Career Researcher Grant
Future-Oriented Mental Imagery and Adolescent Suicide Risk
Ki Eun Shin, Ph.D. · $140,000